Identification of a NK-1R Antagonist as a Novel Therapeutic Approach in Colon Cancer by High Throughput Chemical Screening

被引：0
|
作者：
Polytarchou, Christos
Palumbo, Tiziana
Bugni, James M.
Pothoulakis, Charalabos
Iliopoulos, Dimitrios
机构：
来源：
GASTROENTEROLOGY | 2012年 / 142卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S117 / S118
页数：2
相关论文
共 50 条
  • [1] Effects of a neurokinin-1 receptor (NK-1R) antagonist on colon cancer through suppression of colon tumor-initiating cells
    Polytarchou, C.
    Bugni, J. M.
    Dry, S.
    Pothoulakis, C.
    Iliopoulos, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] Identification of novel inhibitors of Arginase-1 for cancer immunotherapy by high-throughput screening
    Grobben, Y.
    Uitdehaag, J. C. M.
    Willemsen-Seegers, N.
    Tabak, W. W. A.
    van Groningen, J.
    Friesen, J.
    Rutjes, H.
    de Man, J.
    Buijsman, R. C.
    Zaman, G. J. R.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E78 - E78
  • [3] High-throughput screening strategies for targeted identification of therapeutic compounds in colorectal cancer
    Bialkowska, Agnieszka B.
    Yang, Vincent W.
    FUTURE ONCOLOGY, 2012, 8 (03) : 259 - 272
  • [4] High-throughput synthetic lethal interaction screening in model organisms as a strategy for the identification of novel therapeutic targets in cancer
    Srivas, Rohith
    Shen, John Paul
    Li, Jian Feng
    Licon, Katherine
    Wang, Ze Zhong
    Bojoquez-Gomez, Ana
    Xu, Lucy
    Gross, Andrew
    Bean, Gordon
    Sobol, Robert
    Ideker, Trey
    MOLECULAR CANCER RESEARCH, 2014, 12
  • [5] Identification of Novel IGF1R Kinase Inhibitors by Molecular Modeling and High-Throughput Screening
    Moriev, R.
    Vasylchenko, O.
    Platonov, M.
    Grygorenko, O.
    Volkova, K.
    Zozulya, S.
    ACTA NATURAE, 2013, 5 (02): : 90 - 99
  • [6] Identification and validation of vesicant therapeutic targets using a high-throughput siRNA screening approach
    Albert L. Ruff
    Sarah Beach
    John Lehman
    Cristin Rothwell
    James F. Dillman
    Archives of Toxicology, 2016, 90 : 375 - 383
  • [7] Identification of novel subtype-specific therapeutic approaches by high throughput drug screening in PDAC
    Doffo, M. J.
    Esposito, I.
    Keller, U.
    Wirth, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 291 - 291
  • [8] Identification and validation of vesicant therapeutic targets using a high-throughput siRNA screening approach
    Ruff, Albert L.
    Beach, Sarah
    Lehman, John
    Rothwell, Cristin
    Dillman, James F.
    ARCHIVES OF TOXICOLOGY, 2016, 90 (02) : 375 - 383
  • [9] Kinesin spindle protein inhibitors in cancer: from high throughput screening to novel therapeutic strategies
    Shahin, Rand
    Aljamal, Salah
    FUTURE SCIENCE OA, 2022, 8 (03):
  • [10] Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension High-Throughput Screening of 5562 Compounds
    Kurosawa, Ryo
    Satoh, Kimio
    Kikuchi, Nobuhiro
    Kikuchi, Haruhisa
    Saigusa, Daisuke
    Al-Mamun, Md. Elias
    Siddique, Mohammad A. H.
    Omura, Junichi
    Satoh, Taijyu
    Sunamura, Shinichiro
    Nogi, Masamichi
    Numano, Kazuhiko
    Miyata, Satoshi
    Uruno, Akira
    Kano, Kuniyuki
    Matsumoto, Yotaro
    Doi, Takayuki
    Aoki, Junken
    Oshima, Yoshiteru
    Yamamoto, Masayuki
    Shimokawa, Hiroaki
    CIRCULATION RESEARCH, 2019, 125 (03) : 309 - 327
12345